subgroup of
trial)
→
CapableOf
→
assess pharmacokinetic
| Typicality: | 0.420 |
| Saliency: | 0.400 |
| in infants | 3 | location |
| phase trial → assess → pharmacokinetic | 3 |
| phase trial → evaluate → pharmacokinetic | 3 |
| negative | neutral | positive |
| 0.012 | 0.878 | 0.110 |
| Raw frequency | 6 |
| Normalized frequency | 0.400 |
| Modifier score | 0.500 |
| Perplexity | 87.595 |